| HOME >> BIOLOGY >> TECHNOLOGY |
in joint venture 6,000 (2,000) 6,000 (1,000)
Other income - - 25,000 0
119,000 58,000 254,000 143,000
Net loss ($62,000) ($86,000) ($54,000) ($193,000)
Net loss per share -
basic ($0.00) ($0.01) ($0.00) ($0.01)
Net loss per share -
diluted ($0.00) ($0.01) ($0.00) ($0.01)
Weighted average
common shares
outstanding -
basic 16,979,623 16,999,623 16,961,344 16,998,414
Weighted average
common shares
outstanding -
diluted 16,979,623 16,999,623 16,961,344 16,998,414
CONDENSED BALANCE SHEET
(Unaudited)
December 31, June 30,
2007 2008
Cash and marketable securities $8,804,000 $8,590,000
Other current assets 167,000 137,000
Total assets $8,971,000 $8,727,000
Current liabilities $128,000 $119,000
Minority interest in joint venture 11,000 19,000
Total stockholders' equity 8,832,000 8,589,000
Total liabilities and equity $8,971,000 $8,727,000
| SOURCE AutoImmune Inc. Copyright©2008 PR Newswire. All rights reserved |